Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib effectively treats severe alopecia areata and is safe.

Deucravacitinib helped a man regrow hair and improve psoriasis.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

Testing for the NUDT 15 variant is crucial before starting azathioprine, especially in Asians.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Pantethine may boost the immune system's ability to fight sarcoma.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

New isatin-gallate hybrids show promise as antioxidants, cancer treatments, and coronavirus inhibitors.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

New inhibitors may reduce gut toxicity from cancer drugs.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Erythrina subumbrans leaves may help treat hair loss.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Vinblastine and its metabolites may cause nausea and hair loss by binding to specific receptors and could lead to better chemotherapy drugs with fewer side effects.

Personalized sonidegib dosing can effectively treat Gorlin-Goltz syndrome with fewer side effects.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

A new method improves betulin delivery and shows promise in cancer treatment.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

EGFR inhibitors for lung cancer can cause severe skin issues.